CARL
Carlsmed, Inc. Common Stock
NASDAQ: CARL · HEALTHCARE · HEALTH INFORMATION SERVICES
$8.89
+0.68% today
Updated 2026-04-30
Market cap
$283.89M
P/E ratio
—
P/S ratio
5.62x
EPS (TTM)
$-2.12
Dividend yield
—
52W range
$0 – $17
Volume
0.1M
Carlsmed, Inc. Common Stock (CARL) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | $13.78M | $27.16M | $50.51M |
| Revenue growth (YoY) | — | +97.2% | +85.9% |
| Cost of revenue | $3.88M | $7.12M | $12.47M |
| Gross profit | $9.90M | $20.05M | $38.04M |
| Gross margin | 71.9% | 73.8% | 75.3% |
| R&D | $7.39M | $14.30M | $17.02M |
| SG&A | $6.00M | $8.39M | $16.57M |
| Operating income | $-18.59M | $-24.12M | $-30.57M |
| Operating margin | -134.9% | -88.8% | -60.5% |
| EBITDA | $-18.12M | $-22.79M | $-28.51M |
| EBITDA margin | -131.5% | -83.9% | -56.4% |
| EBIT | $-18.26M | $-22.94M | $-28.79M |
| Interest expense | $641000.00 | $1.32M | $1.43M |
| Income tax | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% |
| Net income | $-18.90M | $-24.26M | $-30.22M |
| Net income growth (YoY) | — | -28.4% | -24.6% |
| Profit margin | -137.2% | -89.3% | -59.8% |